Correction: IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages
Lizong Rao(Central South University), Huilan Zhang(Tongji Hospital), Ting Yuan(Goethe University Frankfurt), Jianping Zhao(Xinjiang University), Xingxu Huang(Chinese National Human Genome Center), Guorao Wu(Tongji Hospital), Bin Cheng(Tongji Hospital), Longmin Chen(Tongji Hospital), Fei Sun(Ningxia Medical University), Huiren Lei(Guilin Medical University), Yi Wang(Chinese Academy of Sciences), Lu Zhang(Tongji Hospital), Lei Zhang(Macau University of Science and Technology), Shu Zhang(Capital Medical University), Jinxiu Li(Yunnan University), Biwen Mo(Guilin Medical University), Yongjian Xu(Ningbo University), Qilin Yu(Tongji Hospital), Jianghong Wei(Guilin Medical University), Faxi Wang(Wuhan University), Song Jia(Tongji Hospital), Cong‐Yi Wang(Ministry of Education of the People's Republic of China)
Cited by 8
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
|Journal of Allergy and Clinical Immunology|2020|2.4k
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
|Nature Communications|2018|2.1k